User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 22:15, 26 December 2019 (diff | hist) . . (-1) . . m Valproate (→State of the art) (current)
- 22:13, 26 December 2019 (diff | hist) . . (-35) . . m Valproate (→State of the art)
- 22:12, 26 December 2019 (diff | hist) . . (+7) . . m Valproate (→State of the art)
- 22:10, 26 December 2019 (diff | hist) . . (+1) . . m Valproate (→Medical use and TDM)
- 22:09, 26 December 2019 (diff | hist) . . (+1) . . m Valproate (→Medical use and TDM)
- 22:08, 26 December 2019 (diff | hist) . . (-6) . . m Valproate (→Pharmacokinetics of VPA)
- 22:05, 26 December 2019 (diff | hist) . . (-25) . . m Valproate (→Pathophysiology of epilepsy)
- 22:04, 26 December 2019 (diff | hist) . . (+2) . . m Valproate (→Pathophysiology of epilepsy)
- 22:02, 26 December 2019 (diff | hist) . . (0) . . m Valproate (→Pathophysiology of epilepsy)
- 22:02, 26 December 2019 (diff | hist) . . (-50) . . m Valproate (→Mechanism of action)
- 22:00, 26 December 2019 (diff | hist) . . (+4) . . m Valproate (→Genetic Pathophysiology and Seizure types)
- 22:00, 26 December 2019 (diff | hist) . . (+6) . . m Valproate (→Genetic Pathophysiology and Seizure types)
- 21:59, 26 December 2019 (diff | hist) . . (+7) . . m Valproate (→Genetic and General Pathophysiology)
- 21:58, 26 December 2019 (diff | hist) . . (+11) . . m Valproate (→Genetic Pathophysiology)
- 21:53, 26 December 2019 (diff | hist) . . (+3) . . m Valproate (→Structure and interaction with albumin)
- 21:52, 26 December 2019 (diff | hist) . . (0) . . m Valproate (→General)
- 13:39, 26 December 2019 (diff | hist) . . (-4) . . Valproate (→General)
- 15:05, 19 December 2019 (diff | hist) . . (+264) . . Valproate (→Medical use and TDM)
- 15:02, 19 December 2019 (diff | hist) . . (+238) . . Valproate (→Medical use and TDM)
- 14:59, 19 December 2019 (diff | hist) . . (-2) . . Valproate (→Efficacy and influence on hepatic function)
- 14:59, 19 December 2019 (diff | hist) . . (+29) . . Valproate (→Efficacy and influence on hepatic function)
- 14:58, 19 December 2019 (diff | hist) . . (+318) . . Valproate (→Efficacy and influence on hepatic function)
- 14:49, 19 December 2019 (diff | hist) . . (-2) . . Valproate
- 14:48, 19 December 2019 (diff | hist) . . (-3) . . Valproate
- 14:48, 19 December 2019 (diff | hist) . . (-3) . . Valproate
- 12:32, 18 December 2019 (diff | hist) . . (-3) . . Valproate
- 12:31, 18 December 2019 (diff | hist) . . (0) . . Main Page (→SensUs 2020)
- 17:32, 16 December 2019 (diff | hist) . . (+30) . . MediaWiki:Sidebar
- 15:41, 15 December 2019 (diff | hist) . . (-762) . . Valproate
- 02:38, 14 December 2019 (diff | hist) . . (+55) . . Valproate
- 02:28, 14 December 2019 (diff | hist) . . (0) . . Main Page (→SensUs 2019)
- 02:28, 14 December 2019 (diff | hist) . . (-1) . . Main Page (→SensUs 2019)
- 02:26, 14 December 2019 (diff | hist) . . (+5) . . Valproate
- 01:55, 14 December 2019 (diff | hist) . . (0) . . N File:VPA 3D.png (current)
- 01:54, 14 December 2019 (diff | hist) . . (-5) . . Valproate
- 01:43, 14 December 2019 (diff | hist) . . (+28,537) . . Valproate
- 01:15, 13 December 2019 (diff | hist) . . (-27,855) . . Valproate (Undo revision 99 by Techsensus (talk))
- 01:00, 13 December 2019 (diff | hist) . . (+27,855) . . Valproate
- 14:40, 6 November 2019 (diff | hist) . . (+1) . . Valproate
- 14:40, 6 November 2019 (diff | hist) . . (+30) . . N Valproate (Created page with "This page will be online soon.")
- 11:09, 13 May 2019 (diff | hist) . . (-4) . . Adalimumab (current)
- 10:56, 13 May 2019 (diff | hist) . . (-11) . . Adalimumab
- 14:29, 10 May 2019 (diff | hist) . . (+2) . . Adalimumab
- 14:27, 10 May 2019 (diff | hist) . . (+8) . . Adalimumab
- 14:26, 10 May 2019 (diff | hist) . . (-31) . . Adalimumab
- 14:24, 10 May 2019 (diff | hist) . . (-25) . . Adalimumab
- 17:53, 4 February 2019 (diff | hist) . . (-122) . . Adalimumab
- 16:55, 4 February 2019 (diff | hist) . . (+2) . . Adalimumab
- 16:52, 4 February 2019 (diff | hist) . . (+131) . . Adalimumab
- 16:50, 4 February 2019 (diff | hist) . . (-2) . . Adalimumab
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)